Charles P. Theuer
Halozyme Therapeutics (United States)(US)Tracon Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Neurofibromatosis and Schwannoma Cases, Cancer Cells and Metastasis, Glioma Diagnosis and Treatment, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma(2005)1,630 cited
- → Tuberculosis in Patients with the Acquired Immunodeficiency Syndrome: Clinical Features, Response to Therapy, and Survival(1987)459 cited
- → In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radiolabeled Mesoporous Silica Nanoparticles(2013)341 cited
- → In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nanographene(2012)315 cited
- → Human Immunodeficiency Virus Infection in Tuberculosis Patients(1990)249 cited
- → Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy(2014)243 cited